Subsequent analyses revealed that the NKX3‐1 rs2228013, CASP9 rs1052571, and CASP9 rs4645982 polymorphisms were associated with greater PCa risk, whereas the CASP3 rs4647603 polymorphism was associated with a risk reduction. The gene discussed is CASP9; the disease is posterior cortical atrophy.